Effect of liposomal bupivacaine thoracic paravertebral block on postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery: a randomized controlled trial

View at publisher
Authors: Jing Li, Yong-Tang Li, Li Tang, Hong-Ying Xue, Xue Song, Qing-Ren Liu
Cited by: 2
References: 27

Abstract

BACKGROUND: Thoracic paravertebral block (TPVB) can provide effective analgesia for patients undergoing video-assisted thoracoscopic surgery (VATS). However, the duration of analgesia achieved with conventional local anesthetics combined with dexamethasone remains limited. This study aimed to determine if liposomal bupivacaine (LB) is superior to bupivacaine combined with dexamethasone (BD) with respect to duration of postoperative analgesia in VATS patients. METHODS: Adults scheduled for VATS were randomized to treatment with LB or BD. The primary outcome was duration of analgesia. Secondary outcomes involved Numeric Rating Scale (NRS) pain scores, cumulative oxycodone consumption, total intraoperative sufentanil consumption, first times to ambulation and flatus, length of hospital stay, patient satisfaction level, and incidence of adverse reactions. RESULTS: Of 93 total subjects, 78 were randomized into two groups (n=39 each). The LB group demonstrated a significantly prolonged duration of analgesia compared with the BD group (1160.4±403.8 min vs 743.1±216.8 min, p

Fields of Study & Subjects

Anesthesia and Pain Management Nausea and vomiting management Cancer Stress Anesthesia and Immune Response

Publication details

Journal / source
Regional Anesthesia & Pain Medicine
Publisher
BMJ
Pages
rapm–2025
Publication date
23 March 2026
Language
EN